191 research outputs found
Molecular genetic characteristics of elite rugby union athletes
The capacity to achieve elite athletic success is known to be highly heritable and physiologically complex. Recently, there has been a substantial rise in the number of peer reviewed sports genomics publications, however the majority of these have focused on the genetic components of either strength/sprint/power or endurance athletes, with little attention given to team sports. Since rugby union (RU) athletes perform under a well-defined set of rules and parameters, which are ubiquitous across all playing positions, they present an ideal cohort via which to study the importance of genetic variation in sport and as such is the purpose of the present thesis. The aims of the present thesis were, firstly, to recruit a large cohort of elite RU athletes and compare the genetic profile of these athletes to that of a control population. Secondly, because of the large physiological differences between elite RU playing position, the present thesis further aimed to compare the genetic diversity in RU inter-positional variation. 1164 participants, consisting of 454 elite RU athletes and 710 controls from the general population were recruited for the present thesis. Genotyping data was generated for SNPs within the APOE ε4 (rs429358 and rs7412), ACTN3 (rs1815739), ACE I/D or ACE tag SNP (rs4341), COL5A1 (rs12722 and rs3196378) and FTO (rs9939609) genes. Only the COL5A1 SNPs were different when comparing the entire elite RU cohort to controls. However, observations of APOE ε4 frequency did reveal that ~30% of elite RU athletes are at higher risk of poor outcome following mTBI (concussion). Regarding playing position, both ACTN3 and FTO showed position specific variation, with the greatest associations in the backs playing position. There were no associations between elite RU athletes and controls for ACE I/D. When incorporating all of the above SNPs into a polygenic profile, the entire elite RU cohort, the backs and forwards showed significant deviation from controls. Interestingly by using an ROC model the present thesis identified significant polygenic sensitivity in discriminating between elite RU backs and forwards which trended towards the backs. The data generated in the present thesis are the first to show genetic variation in a large cohort of elite RU athletes, with particular emphasis on positional specificity. These data are only the ‘tip of the iceberg’ in understanding the molecular aspect of elite RU physiological underpinnings and analysis of many more variants are required in addition to replication of the present results. Nonetheless, these data are the first step in this understanding and may have implications in positional selection, position specific training and injury management, in the future. Follow up studies should focus on further recruitment of elite RU athletes and combining genetic data with phenotypic data, specific to elite RU athletes and with particular attention to injury susceptibility
Genomics as a practical tool in sport - have we reached the starting line?
The genetic component of athletic performance approximates 50%, depending on which specific element of performance is considered. Limited genetic testing is already available commercially and genetic tests are likely to become powerful tools to improve sport performance in the future. Currently, however, selection of athletes for training squads or competition based on genomic data is premature. Larger volumes of longitudinal data within individual sports are needed to determine the efficacy of using genomic data in the management of elite athletes via manipulation of training load and diet based on personal genomic information
Genetic testing in exercise and sport - have direct-to-consumer genetic tests come of age?
The general consensus amongst sport and exercise genetics researchers is that genetic tests based on current
knowledge have little or no role to play in talent identifi cation or the individualised prescription of training
to maximise performance or minimise injury risk. Despite this, genetic tests related to sport and exercise are
widely available on a commercial basis. This study assessed commercially-available genetic tests related to
sport and exercise currently marketed via the internet. Twenty-two companies were identified as providing
direct-to-consumer (DTC) genetic tests marketed in relation to human sport or exercise performance or
injury. The most commonly-tested variant was the R577X SNP in the ACTN3 gene, tested by 85% of the 13
companies that appear to present information about their genetic tests on websites - which corresponds with
our assessment that ACTN3 R577X is currently the polymorphism with the strongest scientific evidence in
support of an association with sport and exercise phenotypes. 54% of companies that present information
about their genetic tests used panels of 2-21 variants, including several with very limited supporting scientific
evidence. 46% of companies tested just a single variant, with very low ability to explain complex sport and
exercise phenotypes. It is particularly disappointing that 41% of companies off ering DTC genetic tests related
to exercise and sport did not appear to state publicly the genetic variants they assess, making scrutiny by
academic scholars and consumers impossible. Companies off ering DTC genetic tests related to sport and
exercise should ensure that they are responsible in their activities
Genomics as a practical tool in sport - have we reached the starting line?
The genetic component of athletic performance approximates 50%, depending on which specific element of performance is considered. Limited genetic testing is already available commercially and genetic tests are likely to become powerful tools to improve sport performance in the future. Currently, however, selection of athletes for training squads or competition based on genomic data is premature. Larger volumes of longitudinal data within individual sports are needed to determine the efficacy of using genomic data in the management of elite athletes via manipulation of training load and diet based on personal genomic information
Caffeine ingestion compromises thermoregulation and does not improve cycling time to exhaustion in the heat among males
Purpose Caffeine is a commonly used ergogenic aid for endurance events; however, its efficacy and safety have been questioned in hot environmental conditions. The aim of this study was to investigate the effects of acute caffeine supplementation on cycling time to exhaustion and thermoregulation in the heat. Methods In a double-blind, randomised, cross-over trial, 12 healthy caffeine-habituated and unacclimatised males cycled to exhaustion in the heat (35 \ub0C, 40% RH) at an intensity associated with the thermoneutral gas exchange threshold, on two separate occasions, 60 min after ingesting caffeine (5 mg/kg) or placebo (5 mg/kg). Results There was no effect of caffeine supplementation on cycling time to exhaustion (caffeine; 28.5 \ub1 8.3 min vs. placebo; 29.9 \ub1 8.8 min, P = 0.251). Caffeine increased pulmonary oxygen uptake by 7.4% (P = 0.003), heat production by 7.9% (P = 0.004), whole-body sweat rate by 21% (P = 0.008), evaporative heat transfer by 16.5% (P = 0.006) and decreased estimated skin blood flow by 14.1% (P < 0.001) compared to placebo. Core temperature was higher by 0.6% (P = 0.013) but thermal comfort decreased by -18.3% (P = 0.040), in the caffeine condition, with no changes in rate of perceived exertion (P > 0.05). Conclusion The greater heat production and storage, as indicated by a sustained increase in core temperature, corroborate previous research showing a thermogenic effect of caffeine ingestion. When exercising at the pre-determined gas exchange threshold in the heat, 5 mg/kg of caffeine did not provide a performance benefit and increased the thermal strain of participants
Estimation of conditional laws given an extreme component
Let be a bivariate random vector. The estimation of a probability of
the form is challenging when is large, and a
fruitful approach consists in studying, if it exists, the limiting conditional
distribution of the random vector , suitably normalized, given that
is large. There already exists a wide literature on bivariate models for which
this limiting distribution exists. In this paper, a statistical analysis of
this problem is done. Estimators of the limiting distribution (which is assumed
to exist) and the normalizing functions are provided, as well as an estimator
of the conditional quantile function when the conditioning event is extreme.
Consistency of the estimators is proved and a functional central limit theorem
for the estimator of the limiting distribution is obtained. The small sample
behavior of the estimator of the conditional quantile function is illustrated
through simulations.Comment: 32 pages, 5 figur
Association of Over-The-Counter Pharmaceutical Sales with Influenza-Like-Illnesses to Patient Volume in an Urgent Care Setting
We studied the association between OTC pharmaceutical sales and volume of patients with influenza-like-illnesses (ILI) at an urgent care center over one year. OTC pharmaceutical sales explain 36% of the variance in the patient volume, and each standard deviation increase is associated with 4.7 more patient visits to the urgent care center (p<0.0001). Cross-correlation function analysis demonstrated that OTC pharmaceutical sales are significantly associated with patient volume during non-flu season (p<0.0001), but only the sales of cough and cold (p<0.0001) and thermometer (p<0.0001) categories were significant during flu season with a lag of two and one days, respectively. Our study is the first study to demonstrate and measure the relationship between OTC pharmaceutical sales and urgent care center patient volume, and presents strong evidence that OTC sales predict urgent care center patient volume year round. © 2013 Liu et al
TTN genotype is associated with fascicle length and marathon running performance.
Titin provides a molecular blueprint for muscle sarcomere assembly and sarcomere length can vary according to titin isoform expression. If variations in sarcomere length influence muscle fascicle length, this may provide an advantage for running performance. Thus the aim of this study was to investigate if the titin (TTN) rs10497520 polymorphism was associated with muscle fascicle length in recreationally active men (RA; n = 137) and marathon personal best time in male marathon runners (MR; n = 141). Fascicle length of the vastus lateralis was assessed in vivo using B-mode ultrasonography at 50% of muscle length in RA. All participants provided either a whole blood, saliva or buccal cell sample, from which DNA was isolated and genotyped using real-time polymerase chain reaction. Vastus lateralis fascicle length was 10.4% longer in CC homozygotes, those carrying two copies of the C-allele, than CT heterozygotes (p = 0.003) in RA. In the absence of any TT homozygotes, reflective of the low T-allele frequency within Caucasian populations, it is unclear if fascicle length for this group would have been smaller still. No differences in genotype frequency between the RA and MR groups were observed (p = 0.500), although within the MR group the T-allele carriers demonstrated marathon personal best times 2 min 25 s faster than CC homozygotes (p = 0.020). These results suggest that the T-allele at rs10497520 in the TTN gene is associated with shorter skeletal muscle fascicle length and conveys an advantage for marathon running performance in habitually trained men. This article is protected by copyright. All rights reserved
COL5A1 gene variants previously associated with reduced soft tissue injury risk are associated with elite athlete status in rugby.
BACKGROUND: Two common single nucleotide polymorphisms within the COL5A1 gene (SNPs; rs12722 C/T and rs3196378 C/A) have previously been associated with tendon and ligament pathologies. Given the high incidence of tendon and ligament injuries in elite rugby athletes, we hypothesised that both SNPs would be associated with career success. RESULTS: In 1105 participants (RugbyGene project), comprising 460 elite rugby union (RU), 88 elite rugby league athletes and 565 non-athlete controls, DNA was collected and genotyped for the COL5A1 rs12722 and rs3196378 variants using real-time PCR. For rs12722, the injury-protective CC genotype and C allele were more common in all athletes (21% and 47%, respectively) and RU athletes (22% and 48%) than in controls (16% and 41%, P ≤ 0.01). For rs3196378, the CC genotype and C allele were overrepresented in all athletes (23% and 48%) and RU athletes (24% and 49%) compared with controls (16% and 41%, P ≤ 0.02). The CC genotype in particular was overrepresented in the back and centres (24%) compared with controls, with more than twice the odds (OR = 2.25, P = 0.006) of possessing the injury-protective CC genotype. Furthermore, when considering both SNPs simultaneously, the CC-CC SNP-SNP combination and C-C inferred allele combination were higher in all the athlete groups (≥18% and ≥43%) compared with controls (13% and 40%; P = 0.01). However, no genotype differences were identified for either SNP when RU playing positions were compared directly with each other. CONCLUSION: It appears that the C alleles, CC genotypes and resulting combinations of both rs12722 and rs3196378 are beneficial for rugby athletes to achieve elite status and carriage of these variants may impart an inherited resistance against soft tissue injury, despite exposure to the high-risk environment of elite rugby. These data have implications for the management of inter-individual differences in injury risk amongst elite athletes
Genetic Polymorphisms Related to VO2max Adaptation Are Associated With Elite Rugby Union Status and Competitive Marathon Performance
PURPOSE: Genetic polymorphisms have been associated with the adaptation to training in maximal oxygen uptake (V˙O2max). However, the genotype distribution of selected polymorphisms in athletic cohorts is unknown, with their influence on performance characteristics also undetermined. This study investigated whether the genotype distributions of 3 polymorphisms previously associated with V˙O2max training adaptation are associated with elite athlete status and performance characteristics in runners and rugby athletes, competitors for whom aerobic metabolism is important. METHODS: Genomic DNA was collected from 732 men including 165 long-distance runners, 212 elite rugby union athletes, and 355 nonathletes. Genotype and allele frequencies of PRDM1 rs10499043 C/T, GRIN3A rs1535628 G/A, and KCNH8 rs4973706 T/C were compared between athletes and nonathletes. Personal-best marathon times in runners, as well as in-game performance variables and playing position, of rugby athletes were analyzed according to genotype. RESULTS: Runners with PRDM1 T alleles recorded marathon times ∼3 minutes faster than CC homozygotes (02:27:55 [00:07:32] h vs 02:31:03 [00:08:24] h, P = .023). Rugby athletes had 1.57 times greater odds of possessing the KCNH8 TT genotype than nonathletes (65.5% vs 54.7%, χ2 = 6.494, P = .013). No other associations were identified. CONCLUSIONS: This study is the first to demonstrate that polymorphisms previously associated with V˙O2max training adaptations in nonathletes are also associated with marathon performance (PRDM1) and elite rugby union status (KCNH8). The genotypes and alleles previously associated with superior endurance-training adaptation appear to be advantageous in long-distance running and achieving elite status in rugby union
- …